Helen Torley, PRESIDENT AND CEO at HALOZYME THERAPEUTICS, INC. (HALO), sold 10,000 shares at $63.14 ($635K) on 2026-04-06, disclosed to the SEC on 2026-04-07.
Scheduled sale ($635k) by PRESIDENT AND CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.14 | 5,900 | $373K | 58.7% |
| 2 | $64.02 | 4,100 | $262K | 41.3% |
| Total | $63.50 avg | 10,000 | $635K | 100% |
| Filing → |
| HALO | SELL | 2026-07-09 | $153K | — | Filing → |
| HALO | SELL | 2026-06-03 | $3.4M | — | Filing → |
| HALO | SELL | 2026-05-13 | $3.4M | — | Filing → |